Is early detection of cancer with circulating biomarkers feasible?

Clinical Chemistry

Volumn 59, Issue 1, 2013, Pages 35-37

  Konforte, Danijela ^a,b   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; DNA MODIFICATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; HUMAN; MAMMOGRAPHY; OVARY CANCER; PROTEIN PROCESSING; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SURVIVAL RATE; TRANSVAGINAL ECHOGRAPHY; TUMOR CELL; TUMOR VOLUME;

EARLY DIAGNOSIS; FEASIBILITY STUDIES; FEMALE; HUMANS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872024082     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.184903     Document Type: Short Survey

References (5)

1. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-47.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
3. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-61. (Pubitemid 32717537)
4. Diamandis EP. Cancer biomarkers: Can we turn recent failures into success? J Natl Cancer Inst 2010;102:1462-7.
5. Hori SS, Gambhir SS. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations. Sci Transl Med 2011;3:109ra116.